Remission of natural‐killer cell lymphoma of the liver with anti‐hepatitis C therapy | Zendy

Armor Jess F. | Zendy; Fazili Javid | Zendy; Toubia Nagib | Zendy; Kern William | Zendy; Kamble Rammurti | Zendy; KharfanDabaja Mohamed A. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Remission of natural‐killer cell lymphoma of the liver with anti‐hepatitis C therapy

Author(s) -

Armor Jess F.,

Fazili Javid,

Toubia Nagib,

Kern William,

Kamble Rammurti,

KharfanDabaja Mohamed A.

Publication year - 2005

Publication title -

american journal of hematology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.456

H-Index - 105

eISSN - 1096-8652

pISSN - 0361-8609

DOI - 10.1002/ajh.20286

Subject(s) - lymphoma , medicine , malignancy , hepatitis c , immunology , neoplasm , hepatitis , natural killer cell , leukemia , pathology , biology , cytotoxicity , biochemistry , in vitro

Non‐Hodgkin lymphomas (NHL) consist of a diverse group of lymphoproliferative neoplasms with unique patterns of biology, behavior, and differing responses to therapy. A rare subtype of malignancy arising from cells of putative natural killer (NK) origin is being recognized as a distinct clinicopathological entity. Viruses including hepatitis C have been reported in association with various types of NHL but not the NK‐cell subtype. We hereby report a unique case of a patient with hepatitis C who developed hepatic NK‐cell lymphoma and chronic NK‐cell leukemia. Interestingly, we observed clinical and radiologic remission of the neoplasm following treatment with anti‐hepatitis C therapy. Am. J. Hematol. 78:212–215, 2005. © 2005 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research